View Author
scopus: 8245388600

Pires, N.M.M.

(Nuno Pires)


restenosi polymorphism patient factor study leiden block plasminogen activator inhibitor haplotype center stent vitamin vdr gene netherland department association analysis effect receptor genotype allele diabetes result level target cardiology 2012-08-03 | id factor v leiden targets downloaded expert erasmus mc university 1000521777 | ip percutaneou intervention monraat inhibitor downloaded thromb risk marker stent placement plasminogen event frequency variant table genotyping activator smoker leiden university regression 4 g variant erasmu distribution population angioplasty month model procoagulant polymorphisms response van meurs jb disease development haemost plasma vdr haplotype effects artery identi fied follow-up heart expert opin system additive marker block 2 gender population protein c drug-eluting stents gender signi




2 Most Recent Publications

Vitamin D receptor: A new risk marker for clinical restenosis after percutaneous coronary intervention (Article)
Monraats, P.S. Fang, Y. Waltenberger, J. Frants, R.R. Quax, P.H.A. Laarse, A. van der Wall, E.E. van der Uitterlinden, A.G. Jukema, J.W. Pons, D. Pires, N.M.M. Pols, H.A.P. Zwinderman, A.H. Maat, M.P.M. de Doevendans, P.A. Dewinter, R.J. Tio, R.A.
2010-03-01
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions (Article)
Pons, D. Monraats, P.S. Winter, R.J. de Tio, R.A. Frants, R.R. Laarse, A. van der Wall, E.E. van der Jukema, J.W. Maat, M.P.M. de Pires, N.M.M. Quax, P.H.A. Vlijmen, B.J.M. van Rosendaal, F.R. Zwinderman, A.H. Doevendans, P.A. Waltenberger, J.
2007-12-01